Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Channel Catalog


Channel Description:

Cell Culture market research products provide analysis of the latest trends, developments and market data for this industry. Research information will help you make informed business decisions.

older | 1 | .... | 9 | 10 | (Page 11) | 12 | 13 | .... | 17 | newer

    0 0

    Global Single Cell Analysis Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022 The global single cell analysis market is estimated to grow at CAGR of 18.5% during 2016-2022. The single cell analysis is segmented on the basis of application, cell type, product, end user, technique and geography. The application segment is segmented into research application and medical application. The end user segment is also segmented into biotechnology and biopharmaceutical companies, cell banks and IVF centers, hospitals and diagnostic laboratories and research & academic laboratories. the cell type segment is segmented into animal cells, human cells and microbial cells. The single cell analysis market is dominated by some of the major key players such as Becton, Dickinson and Company, Bioheart, Corning, Inc., Medtronic’s PLC, Celgene Corporation, GE Healthcare, Illumina Inc., Merck KGAA, Nanostring technologies Inc., Stem cell Technologies, Stryker Corporation, Thermo Fisher Scientific, Inc.In 2015, the Medtronic has announced that they had completed the acquisition of Covidien plc. which was an Irish-headquartered global health care products company and manufacturer and supplier of medical devices. The Increased funding by government and private firms in research and development are snowballing the scope of single cell analysis market. Although the growing and

    0 0

    The Global Cell Culture Media Market Research Report 2016 is a professional and in-depth study on the current state of the cell culture media market. Annual estimates and forecasts are provided for the period 2015 through 2021. Also, a six-year historic analysis is provided for these markets. The global market for cell culture media is expected to reach about 2100 M USD by 2021 from 1520 M USD in 2016, registering a Compounded Annual Growth Rate (CAGR) of 6.28% during the analysis period, 2016-2021. This report studies Cell Culture Media in Global market, especially in North America, China, Europe, Asia (Ex. China), focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Life Technologies Corning (Cellgro) Sigma-Aldrich Thermo Fisher merck Millipore GE Healthcare Lonza BD HiMedia Takara CellGenix Atlanta Biologicals PromoCell Zenbio market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Cell Culture Media in these regions, from 2011 to 2021 (forecast), like North America China Europe Asia (Ex. China) Split by product types, with sales, revenue, price, and market share and growth rate of each type, can be divided into Classical Media & Salts Serum-free Media Stem Cell Media Other Split by applications, this report focuses on sales, market share and growth

    0 0

    3D Cell Culture - Global Market Outlook (2016-2022) According to Stratistics MRC, the Global 3D Cell Culture Market is accounted for $375.25 million in 2015 and is expected to reach $1520.15 million by 2022 growing at a CAGR of 22.1% during the forecast period. Increasing investment and R&D funding for cell based research, technological advancements and increasing demand for organ transplantation & tissue engineering are some of the factors boosting the market growth. However, high cost of research, and dearth of infrastructure for research in developing countries are anticipated to hamper the market growth. Hence it is an opportunity for players to increase in R&D spending in the growing market to gain the traction. By technology, scaffold-based segment dominated the global market with largest share owing to variety of material and structural choices for scaffold. North America accounted for largest share in the global market followed by Europe owing to rising government support, increasing incidence of cancer and introduction of new products in the market. Some of the key players in 3D Cell Culture market include Nano 3D Biosciences Inc, Tecan Trading AG, Corning Inc., 3D Biotek LLC, Reinnervate Ltd, Lonza Group, Becton, Dickinson and Company, 3D Biomatrix, Inc., VWR International LLC, PromoCell

    0 0

    2016 Global In Vitro Toxicology Testing Products Industry Report is a professional and in-depth research report on the world's major regional market conditions of the In Vitro Toxicology Testing Products industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the In Vitro Toxicology Testing Products basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. The report includes six parts, dealing with: 1.) basic information; 2.) the Asia In Vitro Toxicology Testing Products industry; 3.) the North American In Vitro Toxicology Testing Products industry; 4.) the European In Vitro Toxicology Testing Products industry; 5.) market entry and investment feasibility; and 6.) the report conclusion.

    0 0

    In Vitro Toxicology Testing - Global Market Outlook (2016-2022) According to Stratistics MRC, the Global In Vitro Toxicology Testing Market is accounted for $12.30 billion in 2015 and is expected to reach $32.45 billion by 2022 growing at a CAGR of 14.8% during the forecast period. Factors such as technological advancements and increasing government funding are fueling the market growth. However, strict regulations and predictive ability of in vitro testing over in vivo testing are hampering the market. Growing drug discovery and innovation in the market provides ample of opportunities for players in the market. Cellular assay segment dominated the global market with largest share due to wider availability of these techniques for pharmacokinetic profiling along with the presence of significant number of market entities operating in the field of biotechnology. North America dominated the market with more than 35% of the global share owing to encouraging government incentives for laboratory expansion in the region. Some of the key players in the market include Thermo Fisher Scientific, Covance Inc., Alere Inc., Catalent Pharma Solutions, Inc., Life Technologies, General Electric Company, Sigma-Aldrich Corporation, Agilent Technologies, Inc., Bioreliance, Inc. (A Subsidiary of Merck Kgaa), Quest Diagnostics Incorporated, Charles River Laboratories International, Inc., Accelrys, Eurofins

    0 0

    Single-Cell Analysis - Global Market Outlook (2016-2022) According to Stratistics MRC, the Global Single-Cell Analysis market is estimated at $1.22 billion in 2015 and is expected to reach $4.25 billion by 2022 growing at a CAGR of 19.5% from 2015 to 2022. Growing Geriatric Population, Government initiatives for research and development and technological advancements are the factors driving the market growth. On the other hand, high initial investment is hampering the market. Encouragement in Stem Cell Research is opportunity for market growth. Consumables in product segment accounted for the largest share and is expected to grow exponentially with highest CAGR, owing to the repeated purchase of products. By geography, North America captured largest market share because of increase in government support for R&D and establishment of pharmaceutical and biotechnology companies. However, Asia Pacific region is estimated to grow at highest CAGR during forecast period owing to healthy growth in R&D and increase in medical tourism in the region. Some of the key players in the market include Merck KGAA, Becton, Dickinson and Company, Johnson & Johnson, Beckman Coulter Inc. (A Subsidiary of Danaher Corporation), EMD Millipore Corporation, Thermo Fisher Scientific, Inc., Epic Sciences, Fluidigm Corporation, Laboratory Corp. of America Inc., Illumina, Inc.,

    0 0

    2016 Global In Vitro Toxicology Testing Products Industry Report is a professional and in-depth research report on the world's major regional market conditions of the In Vitro Toxicology Testing Products industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the In Vitro Toxicology Testing Products basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. The report includes six parts, dealing with: 1.) basic information; 2.) the Asia In Vitro Toxicology Testing Products industry; 3.) the North American In Vitro Toxicology Testing Products industry; 4.) the European In Vitro Toxicology Testing Products industry; 5.) market entry and investment feasibility; and 6.) the report conclusion.

    0 0

    2016 Global Biochemicals Control Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Biochemicals Control industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Biochemicals Control basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. The report includes six parts, dealing with: 1.) basic information; 2.) the Asia Biochemicals Control industry; 3.) the North American Biochemicals Control industry; 4.) the European Biochemicals Control industry; 5.) market entry and investment feasibility; and 6.) the report conclusion.

    0 0

    Cell Isolation/Cell Separation Market by Product (Reagents, Media, Serum, Beads, Centrifuge), Cell Type (Human, Stem, Animal), Technique (Surface marker, Filtration), Application (Cancer, IVD), End User (Hospitals, Biotechnology) - Global Forecast to 2021 The global cell isolation market is expected to reach USD 7.89 billion by 2021 from USD 3.57 billion in 2016, at a CAGR of 17.2%. On the basis of product, the cell isolation market is segmented into consumables and instruments. In 2016, the consumables segment is expected to account for the largest share of the global cell isolation. Growth in this segment can primarily be attributed to the increasing investments by companies to develop advanced products and rising government initiatives for enhancing cell-based research. On the basis of technique, the cell isolation market is segmented into centrifugation-based cell isolation, surface marker-based cell isolation, and filtration-based cell isolation. In 2016, the centrifugation-based cell isolation segment is expected to account for the largest share of the global cell isolation market primarily due to the wide usage of this technique among end users. This system is used on a large scale by biotechnology and biopharmaceutical companies as well as on a small scale by clinical research organizations and academia for manufacturing vaccines, enzymes,

    0 0

    Global 3D Cell Culture Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022 Global 3D Cell Culture Market Research Report 2016 by OBRC, is an extensive study on present state of the 3D Cell Culture Market. 3D cell culture allows culturing of cells in a 3D environment. Adoption rate of 3D cell culture is high amongst research labs, hospitals, and pharmaceutical, biopharmaceutical & biotechnology companies for the forecasted period. Cell biologics, diseases associated to liver, cancer cell therapy are set to drive 3D cell culture market. New innovations in tissue engineering and 3D printing technology have supplemented organ harvesting and transplant. Cell based therapies in hospitals and diagnostic centres for oncology patient are set to propel 3D cell culture market for the forecasted period. Increasing rate of consumers in healthcare in North America and Europe, emerging markets like India and China, are projected to fuel the growth of 3D cell culture market. Increasing cell based research and new innovations in cell culture are the factors driving 3D cell culture market for the forecasted period. Growing demand for organ transplantation and increasing research & development investments are the opportunities in 3D cell culture market for the forecasted period. High investments for cell biology

    0 0

    The global high-throughput screening (HTS) market is estimated to be USD 16.75 billion in 2016 and is projected to reach USD 22.68 billion by 2021, growing at a CAGR of 6.25% during the forecast period. The global high-throughput screening market mainly comprises of target identification & validation, efficacy & safety screening, and monitoring of cell-based activity. High-throughput screening (HTS) is a popular approach to target validation, as it allows the assaying of a large number of potential biological modulators against a chosen set of defined targets. The screening test uses reflectivity measurements, quantifying the extent of binding of any logical entity (e.g. proteins, cells, animal embryo) with the base compound in the wells. The HTC technique can examine/screen 300,000 compounds a day, so it takes only a few weeks to screen millions of substances. The global high-throughput screening market is mainly driven by the adoption of open innovation models by pharmaceutical companies to increase the use of high-throughput screening. Certain other factors include increasing drug discovery initiatives by academic and government institutions to boost the demand for high-throughput screening products, and huge capital investments in high-throughput screening technology by major firms, such as PerkinElmer, Beckman Coulter, and Tecan Group, among others.

    0 0

    The global 3D Cell culture market was valued at an estimated $XX million in 2013 and is poised to grow at a CAGR of XX% from 2013 to 2018, to reach $XX million by 2018. The market is expected to reach USD XX million by 2021, growing at a CAGR of XX% during the forecast period of 2016 to 2021. Cell culture is a process by which prokaryotic cells or eukaryotic cells are artificially grown outside their natural environment in a laboratory under controlled conditions. 3D cell culture is accepted as a new dimension of cell culture sector in biomedical research field. Research laboratories and institutes, hospitals, and biopharmaceutical and biotechnology companies are adopting 3D cell culture for better outputs and the adoption rate is posed to increase rapidly in the near future. The Huge investment by Life science companies for R&D, Development of automated large-scale cell culture systems, Rise in Research and Development Investments, Rising need for organ transplantation, Use of 3D Cell Culture models as an alternative tool for in vivo testing and increasing focus on regenerative medicine are key factors propelling the growth of the market. However, Lack of experienced and skilled professionals, Budget restriction for small and medium

    0 0

    High Throughput Screening (HTS, Consumables, Reagents, Instruments, etc.) This report analyzes the worldwide markets for High Throughput Screening (HTS) in US$ Million by the following Product Segments: Consumables/Reagents, Instruments, and Software and Services. The report also analyses the market by the following Technology Types: Label-Free Technology, Cell-Based Assay, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 104 companies including many key and niche players such as - Agilent Technologies, Inc. Aurora Biomed, Inc. Axxam SpA BD Biosciences Danaher Corporation Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and

    0 0

    High-Throughput Screening Market by Technology (Cell-based Assays (2D & 3D Cell Culture), Lab-on-a-chip, Bioinformatics), Application (Target Identification, Primary Screening, Toxicology), Product (Reagent & Instruments), End User - Forecast to 2021 The high-throughput screening (HTS) market is expected to grow at a lucrative CAGR of 7.8% from 2016 to 2021, to reach USD 18.83 billion by 2021 from USD 12.23 billion in 2016. Market growth can be attributed to the growing adoption of open innovative models in the pharmaceutical and biotechnology industry and technological advancements like automation and miniaturization, increasing R&D spending and rising government funding. Emerging markets and growing research activities in toxicology and stem cells provide significant growth opportunities for the market. On the other hand, the high cost and time-consuming nature of HTS techniques are restraining the growth of this market during the forecast period. The global high-throughput screening market is segmented on the basis of product and service, technology, application end user and region. Based on product and service, the high-throughput screening market is segmented into consumables and reagents, instruments, & software and services. Based on technology, the high-throughput screening market is segmented into cell-based assays; lab-on-a-chip, ultra high-throughput screening market, label-free technology and bioinformatics. The cell-based assays

    0 0

    Influenza Diagnostics Market By Test Type (Rapid Influenza Diagnostic Test [RIDT], Reverse Transcription Polymerase Chain Reaction[RT-PCR], Cell Culture, Others - Immunofluorescence, Serology), By End Use (Hospitals, Laboratories, POCT), And Segment Forecasts To 2024 The influenza diagnostics market is expected to reach USD 3.3 billion by 2024, according to a new report by Grand View Research, Inc. Influenza, or the flu, is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on public health. Influenza A virus poses a greater risk as compared to the influenza B virus. The B virus is responsible for 20% to 25% of infections globally. The growth in the influenza diagnostic market is attributed to factors such as emergence of technologically advanced diagnostic tests with shorter turnaround time; initiatives by regulatory bodies, such as CDC’s seasonal influenza vaccination for prevention and control of seasonal influenza; and the demand created for influenza diagnosis in the flu season. Rapid Influenza Diagnostic Tests (RIDTs) accounted for the largest share in 2015. RIDTs are tests that deliver accurate results in approximately 15 minutes. This factor deems them efficient, which has

    0 0

    3D Cell Culture Technologies Patent Landscape The patent landscape related to 3D cell technologies is very open, involving important academic applicants as well as small companies. It includes over 2,500 patent families and involves over 1,000 patent applicants. Cell culture in two dimensions is widely used for various applications, from fundamental research to biomedical applications. However, this type of culture doesn’t reproduce the natural physiological microenvironment of a cell or an organ. Going from two to three dimensions allows the culture conditions to get closer to the true in vivo environment of the cells and 3D cell culture models are becoming more and more popular. In 2015, the 3D cell culture market was valued at $725 million and is estimated to grow at a CAGR of 30.6% between 2015 and 2020 (source : Meticulous Research, May 2016). Surprisingly, while many companies provide products dedicated to 3D cell culture on the market, these companies don’t appear among the main patent applicants in the IP side of the domain. In fact, the Top-10 of the main assignees owns less than 10% of the whole patent families and no patent assignee is taking over the 3D cell culture domain. This finding indicates that the

    0 0

    Cell Culture Market Analysis & Trends - Product (Consumables (Reagents, Sera & Media), Equipment (Bioreactors & Cell Culture Vessels)), End User (Pharmaceutical & Biotechnology Companies), Application(Stem Cell Technologies & Cancer Research) - Forecast to 2025 The Global Cell Culture Market is poised to grow at a CAGR of around 11.4% over the next decade to reach approximately $33.47 billion by 2025. Some of the prominent trends that the market is witnessing include 3D cell culture will offer a significant opportunity in this market, increased risk of communicable diseases and pandemics, increasing preference for single use technologies and recent technological developments of cell culture. Based on product, the market is categorized into consumables and equipment. By consumable, the market is further segmented into reagents, sera and media. By equipment, the cell culture market is further divided into cell culture supporting equipment, cell culture vessels, bioreactors and cell culture storage equipment. Depending on the end user, the market is segmented into pharmaceutical and biotechnology companies and research institutes. By application, the market is segregated into tissue engineering & regenerative medicine, stem cell technologies, biopharmaceutical/therapeutic applications, drug screening & development, cancer research and other applications. This industry report analyzes the global markets for Cell Culture across all

    0 0

    Global 3D Cell Culture Market Analysis 2016 - Forecast to 2022 Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments. This report analyzes the global markets for "3D Cell Culture". The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to

    0 0

    2016 Global Culture Vessels Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Culture Vessels industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Culture Vessels basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. The report includes six parts, dealing with: 1.) basic information; 2.) the Asia Culture Vessels industry; 3.) the North American Culture Vessels industry; 4.) the European Culture Vessels industry; 5.) market entry and investment feasibility; and 6.) the report conclusion.

    0 0

    2016 Global Single-Cell Analysis Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Single-Cell Analysis industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Single-Cell Analysis basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, capacity utilization, supply, demand and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. The report includes six parts, dealing with: 1.) basic information; 2.) the Asia Single-Cell Analysis industry; 3.) the North American Single-Cell Analysis industry; 4.) the European Single-Cell Analysis industry; 5.) market entry and investment feasibility; and 6.) the report conclusion.

older | 1 | .... | 9 | 10 | (Page 11) | 12 | 13 | .... | 17 | newer